Glaucoma care during the coronavirus disease 2019 pandemic.
Journal
Current opinion in ophthalmology
ISSN: 1531-7021
Titre abrégé: Curr Opin Ophthalmol
Pays: United States
ID NLM: 9011108
Informations de publication
Date de publication:
01 Mar 2021
01 Mar 2021
Historique:
pubmed:
15
12
2020
medline:
16
2
2021
entrez:
14
12
2020
Statut:
ppublish
Résumé
The current article reviews the impact of the coronavirus disease 2019 (COVID-19) pandemic on the delivery of ophthalmic, and specifically, glaucoma care. Literature from the review period includes case series demonstrating the presence of severe acute respiratory syndrome coronavirus 2 RNA in the conjunctival secretions of patients with laboratory-confirmed COVID-19. The global ophthalmology community published reports outlining the enhanced infection control measures undertaken by different institutions around the world to mitigate transmission of the novel coronavirus. Telemedicine has been increasingly implemented in glaucoma practices to reduce in-office patient volume. New data regarding the efficacy and feasibility of tools for home monitoring of intraocular pressure, virtual visual field testing, and remote disc photography are reviewed. COVID-19 has posed a global public health threat due to the severity of its contagion and associated morbidity and mortality. Glaucoma specialists have responded to the pandemic with innovative modifications to reduce viral transmission and optimize patient and staff safety in the office and operating room. The role of teleglaucoma has expanded and will continue to evolve as remote diagnostic devices undergo further refinement and validation.
Identifiants
pubmed: 33315725
pii: 00055735-202103000-00002
doi: 10.1097/ICU.0000000000000730
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
75-82Informations de copyright
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Références
Johns Hopkins University & Medicine. COVID-19 dashboard by the Center for Systems Science and Engineering (CSSE) at John Hopkins University [Internet] 2020. Available from: https://coronavirus.jhu.edu/map.html . [Accessed 1 August 2020].
Chang D, Xu H, Rebaza A, et al. Protecting health-care workers from subclinical coronavirus infection. Lancet Respir Med 2020; 8:e13.
van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med 2020; 382:1564–1567.
Raboud J, Shigayeva A, McGeer A, et al. Risk factors for SARS transmission from patients requiring intubation: a multicentre investigation in Toronto, Canada. PLoS One 2010; 5:e10717.
Cheema M, Aghazadeh H, Nazarali S, et al. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19). Can J Ophthalmol 2020; 55:e125–e129.
Chen L, Liu M, Zhang Z, et al. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Br J Ophthalmol 2020; 104:748–751.
Colavita F, Lapa D, Carletti F, et al. SARS-CoV-2 isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged viral RNA detection. Ann Intern Med 2020; 173:242–243.
Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382:1708–1720.
Daruich A, Martin D, Bremond-Gignac D. Ocular manifestation as first sign of coronavirus disease 2019 (COVID-19): interest of telemedicine during the pandemic context. J Fr Ophtalmol 2020; 43:389–391.
Wu P, Duan F, Luo C, et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol 2020; 138:575–578.
Xia J, Tong J, Liu M, et al. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol 2020; 92:589–594.
Zhou Y, Duan C, Zeng Y, et al. Ocular findings and proportion with conjunctival SARS-COV-2 in COVID-19 patients. Ophthalmology 2020; 127:982–983.
Liang L, Wu P. There may be virus in conjunctival secretion of patients with COVID-19. Acta Ophthalmol 2020; 98:223.
Kumar K, Prakash AA, Gangasagara SB, et al. Presence of viral RNA of SARS-CoV-2 in conjunctival swab specimens of COVID-19 patients. Indian J Ophthalmol 2020; 68:1015–1017.
Xie HT, Jiang SY, Xu KK, et al. SARS-CoV-2 in the ocular surface of COVID-19 patients. Eye Vis (Lond) 2020; 7:23.
Seah IYJ, Anderson DE, Kang AEZ, et al. Assessing viral shedding and infectivity of tears in coronavirus disease 2019 (COVID-19) patients. Ophthalmology 2020; 127:977–979.
Gordon MO, Beiser JA, Brandt JD, et al. The ocular hypertension treatment study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 2002; 120:714–830.
Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ 2020; 369:m1966.
Qiao C, Zhang H, He M, et al. Symptomatic COVID-19 in eye professionals in Wuhan, China. Ophthalmology 2020; 127:1268–1270.
American Academy of Ophthalmology. In memoriam: ophthalmologist deaths from COVID-19 [Internet]. 2020. Available from: https://www.aao.org/coronavirus/deaths . [Accessed 4 June 2020].
Borrelli E, Sacconi R, Querques L, et al. Taking the right measures to control COVID-19 in ophthalmology: the experience of a tertiary eye care referral center in Italy. Eye (Lond) 2020; 34:1175–1176.
Hu VH, Watts E, Burton M, et al. Protecting yourself and your patients from COVID-19 in eye care. Community Eye Health 2020; 33:S1–S6.
Lai THT, Tang EWH, Chau SKY, et al. Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: an experience from Hong Kong. Graefes Arch Clin Exp Ophthalmol 2020; 258:1049–1055.
Leung EH, Flynn HW Jr, Gayer S, et al. Clinical and perioperative management in ophthalmology during the COVID-19 pandemic. Int Ophthalmol Clin 2020; 60:141–158.
Lim LW, Yip LW, Tay HW, et al. Sustainable practice of ophthalmology during COVID-19: challenges and solutions. Graefes Arch Clin Exp Ophthalmol 2020; 258:1427–1436.
Olivia Li JP, Shantha J, Wong TY, et al. Preparedness among ophthalmologists: during and beyond the COVID-19 pandemic. Ophthalmology 2020; 127:569–572.
Parravano M, Borrelli E, Costanzo E, et al. Protect healthcare workers and patients from COVID-19: the experience of two tertiary ophthalmology care referral centers in Italy. Ophthalmol Ther 2020; 9:231–234.
Sengupta S, Honavar SG, Sachdev MS, et al. All India Ophthalmological Society – Indian Journal of Ophthalmology consensus statement on preferred practices during the COVID-19 pandemic. Indian J Ophthalmol 2020; 68:711–724.
Siedlecki J, Brantl V, Schworm B, et al. COVID-19: ophthalmological aspects of the SARS-CoV 2 global pandemic. COVID-19: ophthalmologische aspekte der globalen SARS-CoV-2-pandemie. Klin Monbl Augenheilkd 2020; 237:675–680.
Williams AM, Kalra G, Commiskey PW, et al. Ophthalmology practice during the coronavirus disease 2019 pandemic: the University of Pittsburgh experience in promoting clinic safety and embracing video visits. Ophthalmol Ther 2020; 9:1–9.
Yu AY, Tu R, Shao X, et al. A comprehensive Chinese experience against SARS-CoV-2 in ophthalmology. Eye Vis (Lond) 2020; 7:19.
Wickham L, Hay G, Hamilton R, et al. The impact of COVID policies on acute ophthalmology services-experiences from Moorfields Eye Hospital NHS Foundation Trust. Eye (Lond) 2020; 34:1189–1192.
American Academy of Ophthalmology. Important coronavirus updates for ophthalmologists [Internet] 2020. Available from: https://www.aao.org/headline/alert-important-coronavirus-context . [Accessed 7 May 2020].
Anfinrud P, Stadnytskyi V, Bax CE, Bax A. Visualizing speech-generated oral fluid droplets with laser light scattering. N Engl J Med 2020; 382:2061–2063.
Chuan OS, Bin Razali MA, Shaffiee L, et al. Do slit lamp shields and face masks protect ophthalmologists amidst COVID-19? Ophthalmology 2020; 127:1427–1429.
Liu W, Tang F, Fang L, et al. Risk factors for SARS infection among hospital healthcare workers in Beijing: a case control study. Trop Med Int Health 2009; 14 (S1):52–59.
Du H, Zhang M, Zhang H, Sun X. Practical experience on emergency ophthalmic surgery during the prevalence of COVID-19. Graefes Arch Clin Exp Ophthalmol 2020; 258:1831–1833.
Liu J, Wang AY, Ing EB. Efficacy of slit lamp breath shields. Am J Ophthalmol 2020; 218:120–127.
Wong DHT, Mak ST, Yip NKF, Li KKW. Protective shields for ophthalmic equipment to minimise droplet transmission of COVID-19. Graefes Arch Clin Exp Ophthalmol 2020; 258:1571–1573.
Prum BE Jr, Rosenberg LF, Gedde SJ, et al. Primary open-angle glaucoma Preferred Practice Pattern(®) guidelines. Ophthalmology 2016; 123:41–111.
Junk AK, Chen PP, Lin SC, et al. Disinfection of tonometers: a report by the American Academy of Ophthalmology. Ophthalmology 2017; 124:1867–1875.
Wong B, Parikh D, Rosen L, et al. Comparison of disposable Goldmann applanation tonometer, ICare ic100, and Tonopen XL to standards of care Goldmann nondisposable applanation tonometer for measuring intraocular pressure. J Glaucoma 2018; 27:1119–1124.
Stamper RL. A history of intraocular pressure and its measurement. Optom Vis Sci 2011; 88:E16–E28.
Rödter TH, Knippschild S, Baulig C, Krummenauer F. Meta-analysis of the concordance of Icare ® PRO-based rebound and Goldmann applanation tonometry in glaucoma patients. Eur J Ophthalmol 2020; 30:245–252.
Cook JA, Botello AP, Elders A, et al. Systematic review of the agreement of tonometers with Goldmann applanation tonometry. Ophthalmology 2012; 119:1552–1557.
Britt JM, Clifton BC, Barnebey HS, Mills RP. Microaerosol formation in noncontact ’air-puff’ tonometry. Arch Ophthalmol 1991; 109:225–228.
Lee B, Szirth BC, Fechtner RD, Khouri AS. Are disposable and standard gonioscopy lenses comparable? J Glaucoma 2017; 26:e157–e159.
Shabto JM, De Moraes CG, Cioffi GA, Liebmann JM. Review of hygiene and disinfection recommendations for outpatient glaucoma care: a COVID era update. J Glaucoma 2020; 29:409–416.
American Academy of Ophthalmology. List of urgent and emergent ophthalmic procedures [Internet] 2020. Available from: https://www.aao.org/headline/list-of-urgent-emergent-ophthalmic-procedures . [Accessed 7 May 2020].
Gedde SJ, Feuer WJ, Lim KS, et al. Treatment outcomes in the primary tube versus trabeculectomy study after 3 years of follow-up. Ophthalmology 2020; 127:333–345.
Saheb H, Ahmed II. Micro-invasive glaucoma surgery: current perspectives and future directions. Curr Opin Ophthalmol 2012; 23:96–104.
Husain R, Zhang X, Aung T. Challenges and lessons for managing glaucoma during COVID-19 pandemic: perspectives from Asia. Ophthalmology 2020; 127:e63–e64.
Tran K, Cimon K, Severn M, et al. Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review. PLoS One 2012; 7:e35797.
Kariwa H, Fujii N, Takashima I. Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions and chemical reagents. Dermatology 2006; 212: (Suppl 1): 119–123.
Thomas SM, Jeyaraman MM, Hodge WG, et al. The effectiveness of teleglaucoma versus in-patient examination for glaucoma screening: a systematic review and meta-analysis. PLoS One 2014; 9:e113779.
Cvenkel B, Atanasovska Velkovska M. Self-monitoring of intraocular pressure using Icare HOME tonometry in clinical practice. Clin Ophthalmol 2019; 13:841–847.
Cvenkel B, Velkovska MA, Jordanova VD. Self-measurement with Icare HOME tonometer, patients’ feasibility and acceptability. Eur J Ophthalmol 2020; 30:258–263.
Mudie LI, LaBarre S, Varadaraj V, et al. The Icare HOME (TA022) Study: performance of an intraocular pressure measuring device for self-tonometry by glaucoma patients. Ophthalmology 2016; 123:1675–1684.
Takagi D, Sawada A, Yamamoto T. Evaluation of a new rebound self-tonometer, Icare HOME: comparison with Goldmann applanation tonometer. J Glaucoma 2017; 26:613–618.
Awadalla MS, Qassim A, Hassall M, et al. Using Icare HOME tonometry for follow-up of patients with open-angle glaucoma before and after selective laser trabeculoplasty. Clin Exp Ophthalmol 2020; 48:328–333.
Go MS, Barman NR, House RJ, Freedman SF. Home tonometry assists glaucoma drainage device management in childhood glaucoma. J Glaucoma 2019; 28:818–822.
Kim YW, Kim JS, Lee SY, et al. 24-h intraocular pressure-related patterns from contact lens sensors in normal-tension glaucoma and healthy eyes: the ENIGMA study. Ophthalmology 2020; 127:1487–1497.
Kong YX, He M, Crowston JG, Vingrys AJ. A comparison of perimetric results from a tablet perimeter and Humphrey Field Analyzer in glaucoma patients. Transl Vis Sci Technol 2016; 5:2.
Johnson CA, Thapa S, George Kong YX, Robin AL. Performance of an iPad application to detect moderate and advanced visual field loss in Nepal. Am J Ophthalmol 2017; 182:147–154.
Lowry EA, Hou J, Hennein L, et al. Comparison of Peristat online perimetry with the Humphrey perimetry in a clinic-based setting. Transl Vis Sci Technol 2016; 5:4.
Alawa KA, Nolan RP, Han E, et al. Low-cost, smartphone-based frequency doubling technology visual field testing using a head-mounted display. Br J Ophthalmol 2019; [Online ahead of print].
Mees L, Upadhyaya S, Kumar P, et al. Validation of a head-mounted virtual reality visual field screening device. J Glaucoma 2020; 29:86–91.
Pujari A, Selvan H, Goel S, et al. Smartphone disc photography versus standard stereoscopic disc photography as a teaching tool. J Glaucoma 2019; 28:e109–e111.